Hepatic neoplasm

  • HOME
  • TOPICS
  • Hepatic neoplasm
Editorial
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
Jaewhan Song
Clin Mol Hepatol. 2020;26(4):484-486.   Published online October 1, 2020
View: 6774   Download: 144  Web of Science: 9  Crossref: 10
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
Clin Mol Hepatol. 2020;26(4):480-483.   Published online September 21, 2020
View: 6048   Download: 105  Web of Science: 12  Crossref: 11
Original Article
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
Sunyoung Lee, Seung-seob Kim, Dong ryul Chang, Hyerim Kim, Myeong-Jin Kim
Clin Mol Hepatol. 2020;26(3):340-351.   Published online June 4, 2020
View: 9750   Download: 225  Web of Science: 45  Crossref: 48
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim
Clin Mol Hepatol. 2020;26(3):328-339.   Published online May 28, 2020
View: 9580   Download: 347  Web of Science: 34  Crossref: 34
Editorial
Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
So Yeon Kim
Clin Mol Hepatol. 2020;26(3):309-311.   Published online June 15, 2020
View: 5608   Download: 102  Web of Science: 5  Crossref: 5
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
Sojung Han, Do Young Kim
Clin Mol Hepatol. 2020;26(3):305-308.   Published online July 1, 2020
View: 4999   Download: 115  Web of Science: 5  Crossref: 5
Letter to the Editor
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
Hwi Young Kim, Jean-François Dufour
Clin Mol Hepatol. 2020;26(2):238-239.   Published online March 18, 2020
View: 4634   Download: 66  Web of Science: 1  Crossref: 1
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
Clin Mol Hepatol. 2020;26(2):231-232.   Published online November 4, 2019
View: 4786   Download: 90  Web of Science: 3  Crossref: 3
Original Article
Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan
Clin Mol Hepatol. 2020;26(2):196-208.   Published online January 9, 2020
View: 9227   Download: 283  Web of Science: 17  Crossref: 18
Review
1495
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
Clin Mol Hepatol. 2020;26(2):155-162.   Published online January 15, 2020
View: 11154   Download: 425  Web of Science: 45  Crossref: 41
Letter to the Editor
Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
Nimish Thakral, Douglas A. Simonetto
Clin Mol Hepatol. 2020;26(1):74-77.   Published online August 16, 2019
View: 7579   Download: 149  Web of Science: 7  Crossref: 10
Original Article
Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard
Jamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani
Clin Mol Hepatol. 2020;26(1):54-59.   Published online November 15, 2019
View: 9636   Download: 210  Web of Science: 51  Crossref: 52
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
Ankita Makol, Harpreet Kaur, Sakshi Sharma, Shruthi Kanthaje, Ramanpreet Kaur, Anuradha Chakraborti
Clin Mol Hepatol. 2020;26(1):45-53.   Published online September 30, 2019
View: 8887   Download: 266  Web of Science: 23  Crossref: 17
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol. 2020;26(1):33-44.   Published online June 27, 2019
View: 6799   Download: 199  Web of Science: 21  Crossref: 17
1464
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jin Sil Seong, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol. 2020;26(1):24-32.   Published online May 20, 2019
View: 10623   Download: 309  Web of Science: 30  Crossref: 30
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim
Clin Mol Hepatol. 2019;25(4):390-399.   Published online May 31, 2019
View: 7255   Download: 149  Web of Science: 20  Crossref: 20
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
Kei Moriya, Tadashi Namisaki, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji
Clin Mol Hepatol. 2019;25(4):381-389.   Published online August 13, 2019
View: 6281   Download: 142  Web of Science: 14  Crossref: 12
1461
Ultraselective conventional transarterial chemoembolization: When and how?
Shiro Miyayama
Clin Mol Hepatol. 2019;25(4):344-353.   Published online April 26, 2019
View: 12284   Download: 577  Web of Science: 31  Crossref: 33
1457
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
Clin Mol Hepatol. 2019;25(4):335-343.   Published online March 29, 2019
View: 11973   Download: 256  Web of Science: 45  Crossref: 43
Original Article
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol. 2019;25(3):305-316.   Published online April 19, 2019
View: 7339   Download: 174  Web of Science: 28  Crossref: 25
Review
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol. 2019;25(3):264-269.   Published online March 4, 2019
View: 10896   Download: 339  Web of Science: 51  Crossref: 51
1448
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol. 2019;25(3):245-263.   Published online February 14, 2019
View: 20472   Download: 1,057  Web of Science: 151  Crossref: 160
1442
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol. 2019;25(3):223-233.   Published online January 21, 2019
View: 11630   Download: 426  Web of Science: 29  Crossref: 33
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2019;25(2):168-171.   Published online February 11, 2019
View: 6595   Download: 186  Web of Science: 5  Crossref: 5
Original Article
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol. 2019;25(1):74-85.   Published online February 28, 2019
View: 8097   Download: 209  Web of Science: 22  Crossref: 23
Review
1434
Radiomics and radiogenomics of primary liver cancers
Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
Clin Mol Hepatol. 2019;25(1):21-29.   Published online November 16, 2018
View: 13674   Download: 429  Web of Science: 51  Crossref: 54
1428
Pathologic differential diagnosis of metastatic carcinoma in the liver
Jeong Hwan Park, Jung Ho Kim
Clin Mol Hepatol. 2019;25(1):12-20.   Published online October 5, 2018
View: 27419   Download: 1,141  Web of Science: 45  Crossref: 47
Case Report
Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: case report with 8-year follow up
Hojung Jung, Byung Ik Kim, Yong Kyun Cho, Woo Kyu Jeon, Hong Joo Kim, Hyun Pyo Hong
Clin Mol Hepatol. 2018;24(4):424-429.   Published online November 14, 2017
View: 10673   Download: 178  Crossref: 1

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1059
TOTAL : 2460065
Close layer